The first study monitoring differential expression and AS patterns in whole blood revealed no substantial changes in full-length transcript levels between MS patients and controls, but a highly significant differential expression of a large number of exons, with at least 340 genes predicted to undergo AS.
← all excerpts
Meta-Analysis of Multiple Sclerosis Microarray Data Reveals Dysregulation in RNA Splicing Regulatory Genes.
1
—
—